Press release 🌐 Macro 🌍 United States

EY-Parthenon Forecasts 2% US Deal Volume Growth for 2027

EY-Parthenon expects US deal volume to hold 22% above pre-pandemic averages in 2027, driven by a 4% rise in private equity activity and sustained investment in AI infrastructure, defense, and healthcare.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: SPX → 2/10 (45% confidence).

📊 Affected Assets (1)

SPX
Neutral 🤖 45%
📆 Mid-term 🌍 US ✨ Inferred

A consultancy forecast (not a hard data release) projects US deal volume 2% higher in 2027 and 22% above pre-pandemic averages, with GDP growth slightly above 2% — mildly supportive for large-cap equities via M&A and AI-infrastructure investment. However, the report itself flags elevated borrowing costs, inflation risks and policy uncertainty, and a downside scenario of a 5% drop in deal volumes, so the net directional signal for the index is balanced.

Catalysts
  • • Baseline 2% deal volume growth in 2027 with activity 22% above pre-pandemic averages
  • • Private equity volumes forecast +4% in 2027 on record dry powder deployment
Risk Factors
  • • Downside scenario could see deal volumes fall 5%
  • • Elevated borrowing costs and persistent inflation risks could keep executives cautious

🧭 Full analysis of these assets

🎯 Key Takeaways

  • US deal volume is forecast to grow 2% in 2027, maintaining levels 22% above pre-pandemic averages.
  • Private equity deal volume is projected to increase 4% as firms face pressure to deploy record dry powder.
  • Corporate M&A volume is expected to remain flat year over year, though a downside scenario could see a 5% decline.
  • Real GDP growth is expected to remain slightly above 2% in 2027, supporting continued transaction activity.

📝 Executive Summary

EY-Parthenon projects US deal volume will remain at historically elevated levels in 2027, with a baseline growth forecast of 2%. While corporate M&A is expected to remain flat, private equity activity is projected to rise 4% as firms deploy record dry powder. The outlook assumes real GDP growth slightly above 2%, though analysts warn that elevated borrowing costs and policy uncertainty could trigger a 5% downside scenario.

❓ FAQ

Does this report directly move the stock market?

No. It is a forecast by a consulting practice about future merger activity, not new economic data or a company result, so any market effect is indirect and modest.

What is the overall outlook described?

US deal volume is expected to stay at historically high levels in 2027, growing about 2%, with corporate M&A roughly flat and private equity up 4%, supported by AI infrastructure, defense and healthcare spending.